Navigation Links
Novo Nordisk introduces HemaGo, a mobile application to track hemophilia treatment, bleeding episodes and life events
Date:11/27/2012

PRINCETON, N.J., Nov. 27, 2012 /PRNewswire/ -- Novo Nordisk announced today the introduction of HemaGo, a mobile application (app) to help individuals with hemophilia and their caregivers monitor the details of treatment, including medications, dosing, bleed information and the impact of hemophilia on life events.  

The app offers multiple profiles so that more than one family member can use the tool.  HemaGo helps them track multiple medications, set reminders for treatment or doctor's appointments.  As well, HemaGo can be used to record factor usage and reason for infusion; the type, location and duration of bleeding events; and pain scores, including the impact of the bleeding episode on the individual's participation in work or school. 

"For the first time, individuals can track virtually every aspect of living with a bleeding disorder, regardless of their medication or disorder," said Eddie Williams, Corporate Vice President, Biopharmaceuticals.  "Thanks to input from members in the hemophilia community, we've created a first in class offering that provides benefits to all hemophilia patients and healthcare professionals."

Information from the HemaGo app syncs to Novo Nordisk's Changing Possibilities in Hemophilia website (www.changingpossibilities-us.com).  At the site, individuals have access to comprehensive reporting features, including treatment logs, bleed logs, and quality of life reports.  This information may be shared with the individual's healthcare team, including their hemophilia treatment center and home healthcare company. 

Novo Nordisk does not have access to patient-specific information.  The company's access is restricted to generic information ("de-identified") in which the data has been stripped so that the individual source cannot be identified, in accordance with Health Insurance Portability and Accountability Act of 1996 (HIPAA) Privacy and Security Rules. 

Novo Nordisk is working with the American Thrombosis and Hemostasis Network (ATHN) to enable patients who choose the option to link their diary data with their other medical records on ATHN's national database of bleeding disorder treatment information. 

HemaGo was developed with the participation of Novo Nordisk's Consumer Council, which is comprised of bleeding disorder community members.

HemaGo is available for free download at www.changingpossibilities-us.com.  The Android version is expected to be available in November 2012.  The app's tools are also available from the website for individuals who do not have a mobile device.

Headquartered in Denmark, Novo Nordisk is a global healthcare company with 89 years of innovation and leadership in diabetes care. The company also has leading positions within haemophilia care, growth hormone therapy and hormone replacement therapy. For more information, visit novonordisk.com.

iPhone and iPad are registered trademarks of Apple Inc.

Android is a registered trademark of Google.

 


'/>"/>
SOURCE Novo Nordisk
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Novo Nordisk Supports Four San Francisco-based Organizations In Fight Against Diabetes
2. Novo Nordisk Supports Three Houston-Based Organizations In Fight Against Diabetes
3. Governor Gregoire and Congressman McDermott Join Novo Nordisk at Opening Event for Type 1 Diabetes Research Center in Seattle
4. Anthro Introduces Steves Station Curve at RSNA 2012
5. Filtrona Porous Technologies Introduces New Medical-Grade Foams And Unique Fiber Products For Clean Environments At MEDICA / COMPAMED Trade Fair
6. Richard Wolf Introduces the Smallest Bipolar Resectoscope on the Market
7. Elekta Introduces MOSAIQ Connectivity for its microSelectron Digital Brachytherapy Afterloader at ASTRO Annual Meeting
8. InkSure Introduces FDA Approved High Security Taggants for Direct Food Contact
9. Dynatronics Introduces New SolarisPlus Line of Therapy Products
10. RNL BIO, a South Korean adult stem cell firm, introduces its autologous stem cell therapeutics in Turkey to treat patients with various intractable diseases
11. Olympus Introduces the Worlds First and Only Monopolar, Disposable Tonsil Adenoid Debrider (DTAD)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/4/2017)... 2017 OBP Medical , a ... devices, today announced regulatory approval from ... Agência Nacional de Vigilância Sanitária (ANVISA)) to market ... retractor with integrated LED light source and smoke ... exposure of a tissue pocket or cavity during ...
(Date:10/2/2017)... 2, 2017 The Rebound mobile app is poised ... reverse the tide of prescription drug addiction. The app empowers ... intake and stepping down their dosage in a safe, controlled ... December 2017; the first 100,000 people to sign up will ... http://www.rebound-solution.com/ ...
(Date:9/25/2017)... --  Montrium , an industry leader in powerful ... Trial Master Files & Inspection Readiness Conference ( ... Services has selected eTMF Connect to ... a leading European contract research organization (CRO), will ... enable greater collaboration with sponsors, improve compliance and ...
Breaking Medicine Technology:
(Date:10/13/2017)... Nevada (PRWEB) , ... October 13, 2017 , ... ... Hemp CBD Oil utilizing Purzorb™ technology. Applying the Purzorb™process to full spectrum CBD oil ... required and providing a CBD form that can be easily incorporated into liquid products, ...
(Date:10/13/2017)... BASKING RIDGE, N.J. (PRWEB) , ... October 13, 2017 , ... ... second annual Holly Day Market. Featuring a collection of specialty vendors and unique items ... myriad of personalized and quality-focused health and wellness services offered by the VNA. ...
(Date:10/13/2017)... ... October 13, 2017 , ... Coveros, a leader in agile ... a contract by the Center for Medicare and Medicaid Services (CMS). The Enterprise ... use of Agile methodologies in a consistent and high value manner across CMS ...
(Date:10/12/2017)... New Orleans, LA (PRWEB) , ... October 12, 2017 , ... ... fitness centers in the U.S., announced today its plans to open a flagship location ... club will occupy the former Rooms To Go store next to Office Depot in ...
(Date:10/12/2017)... ... October 12, 2017 , ... Information about ... intend to develop to enable prevention of a major side effect of chemotherapy ... especially in pediatric patients. For cisplatin, hearing loss is FDA listed on-label as ...
Breaking Medicine News(10 mins):